✦ LIBER ✦

A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson’s disease – a subjective view

✍ Scribed by R. Horowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and pharmacogenetic determinant

✍ Maurits E. L. Arbouw; Kris L. L. Movig; Toine C. G. Egberts; Petra J. E. Poels; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 117 KB

Interaction between dopamine and adenosi

✍ M. Morelli; A. Pinna 📂 Article 📅 2001 🏛 Springer Milan 🌐 English ⚖ 41 KB

Mechanisms and Issues Relating to the Us

✍ David E. Nichols; Mechelle M. Lewis 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 401 KB

A molecular basis for the increased vuln

✍ C. Savio Chan; Tracy S. Gertler; D. James Surmeier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 1 views

Neurotoxins and Drugs for the Treatment

✍ M. G. Kadieva; E. T. Oganesyan; S. Kh. Mutsueva 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 178 KB

Interaction of alpha-synuclein and dopam

✍ James E. Galvin 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 509 KB